Severity of COVID19 infection among patients with multiple sclerosis treated with interferon-β
Year: 2022
Type: article
Study design: Observational Study
Authors: Steve Simpson-Yap, Ashkan Pirmani, Edward De Brouwer, Liesbet M. Peeters, Lotte Geys, Tina Parciak, Anne Helme, Jan Hillert, Yves Moreau, Gilles Edan, Tim Spelman, Sifat Sharmin, Robert McBurney, Hollie Schmidt, Arnfin Bergmann, Stefan Braune, Alexander Stahmann, Rodden Middleton, Amber Salter, Bruce Bebo, Anneke van der Walt, Helmut Butzkueven, Serkan Ozakbas, Rana Karabudak, Cavit Boz, Raed Alroughani, Juan I Rojas, Ingrid van der Mei, Guilherme Sciascia do Olival, Melinda Magyari, Ricardo Alonso, Richard Nicholas, Anibal Chertcoff, Ana Zabalza, Georgina Arrambide, Nupur Nag, Annabel Descamps, Lars Costers, Ruth Dobson, Aleisha Miller, Paulo Rodrigues, Vesna Prčkovska, Giancarlo Comi, Tomas Kalincik
Institutions: University of Tasmania, The University of Melbourne, Menzies Institute for Medical Research, Hasselt University, KU Leuven, Karolinska Institutet, Hôpital Pontchaillou, National Multiple Sclerosis Society, Swansea University, Washington University in St. Louis, Monash University, Amiri Hospital, Hacettepe University, Karadeniz Technical University, Dokuz Eylül University, Centro de Educación Médica e Investigaciones Clínicas Norberto Quirno, Rigshospitalet, Danish Multiple Sclerosis Center, Hospital Ramos Mejía, Imperial College London, Hospital Británico de Buenos Aires, Universitat Autònoma de Barcelona, Vall d'Hebron Institut de Recerca, Vall d'Hebron Hospital Universitari, Centre d'Esclerosi Múltiple de Catalunya, Icometrix (Belgium), Queen Mary University of London, Vita-Salute San Raffaele University, The Royal Melbourne Hospital
Language: English
Subfield: Clinical Neurology
Field: Medicine
Domain: Health Sciences
Open Access status: green
Funders: U.S. Department of Defense, National Multiple Sclerosis Society, Sanofi, Biogen, Patient-Centered Outcomes Research Institute, Teva Pharmaceutical Industries, Celgene, Merck KGaA, Barts Charity, Mylan, Multiple Sclerosis Trust, Multiple Sclerosis Australia, Vetenskapsrådet, Servier, Gemeinsame Bundesausschuss, EMD Serono, Sanofi Genzyme, National Health and Medical Research Council
Award: G7414070065
OpenAlex ID: W4287512401